Introduction
============

Orofacial clefts (OFC) represent one of the most common birth defects, occurring frequently in Asians and Amerindians [@B01]-[@B03]. Affected subjects tend to have language and hearing problems and difficulty in social integration, therefore multidisciplinary care is required in order to improve health status [@B04].

Based on their association with specific malformative patterns or their presence as isolated defects, OFCs can be classified as syndromic (SF) and nonsyndromic form (NSF), respectively [@B05]. Approximately 30% of cases of Cleft Lip and Palate (CLP) occur as SF [@B06],[@B07]. Patients affected by SF tend to have higher morbidity and mortality throughout life due to their associated congenital anomalies [@B04]. Given the complex etiology and pathogenesis of these anomalies, patients need genetic assessment to establish an accurate diagnosis and appropriate risk management [@B08].

The prevalence of OFCs depends largely on factors such as ethnicity and geographic region [@B09]. Frequently, facial clefts are associated with other congenital defects [@B04],[@B10]. The study of past medical and family history and associated anomalies is useful in understanding inheritance patterns, risk factors and in providing public health strategies [@B08].

No research in Colombia has addressed a complete descriptive epidemiology of OFC or the relationship of OFC with some clinical aspects [@B11],[@B12], therefore providing epidemiological information is a research priority area. The current study was designed to: 1) present the frequency of cleft type, associated congenital anomalies, syndromic, non-syndromic and multiple malformation forms; 2) determinate associations between syndromic forms and antenatal high- risk conditions, preterm birth and comorbidities.

Materials and Methods
=====================

Subjects
--------

Three hundred and eleven individuals with Orofacial Clefts aged between 3 weeks and 52 yrs who attended at Operation Smile Colombia from April 2012 to July 2013 were assessed by Medical Genetics Team at Operation Smile Colombia. A recruiting was not performed. The whole population was included in this study. Sampling was not carried out. 168 (52%) were males, 149 (48%) were females. Distribution by age is shown in [Table 1](#t01){ref-type="table"}. Ethical principles for medical research involving human subjects, as outlined in the declaration of Helsinki were followed. Universidad de La Sabana ethical committee approved the study protocol.

Table 1.Sex, age and region of origin (N= 311).Variablen%SexMale16854Female14948Age range (yrs)\<1 m72\<1105342-541136-11501612-175819≥185016Origin areaRural13744Urban17456[^2]

Procedure
---------

Information about sex, type of cleft, past medical and family history was recorded in children (\<18 yrs) and adults (≥18 yrs). In children, maternal, and pediatric history were recorded focusing on antenatal high-risk conditions, the presence or absence of preterm birth, comorbidities and neonatal diseases. Pregnancy dietary supplements and /or folate intakes were not assessed. Preterm birth was defined as delivery at ≤37 weeks gestation. Two trained physicians in clinical genetics performed a physical examination focusing on identifying other congenital anomalies and establishing a clinical diagnosis.

Based on clinical features the patients were classified into 3 categories:

1\. Non- syndromic form (NSF): patients affected by isolated OFCs.

2\. Syndromic form (SF): patients affected by OFCs and a specific syndrome can be recognized (OMIM).

3\. Multiple malformation form (MMF): patients affected by OFCs and other malformations but a specific syndrome cannot be recognized.

4\. A whole-exome sequencing was used to resolve clinical diagnoses for some syndromic phenotypes.

Data analysis
-------------

Cross tabulation was used to analyze the frequency distribution of the variables (sex, age, region of origin, cleft type, affected-side, clinical form, associate anomalies, morbidities). In order to determinate a measure of association between the occurrences of interest (antenatal high-risk conditions, presence or absence of preterm birth, and comorbidities) and SF of OFC, two cases were defined. Case 1: cases with SF (224). Case 2: cases with NSF (59). Taking into account MMF does not have any specific pattern it was not included in any case group.

Chi-square statistics, Fisher´s exact test and odds ratio (OR) calculations were used to determine associations. The frequency of the ocurrences in SF group to NSF group was compared. Results were considered to be significant at *p*\<0.05. All data were analyzed using Epi Info version 7^®^ [@B13].

Results
=======

The most common sex, age range and region of origin were male, 1-23 months and urban area respectively ([Table 1](#t01){ref-type="table"}). The most frequent type of OFC was CLP (69%). Analysis of cleft type by sex showed that CLP was more frequent in males, whereas Cleft Palate (CP) occurred more often in females ([Table 2](#t02){ref-type="table"}). The majority of CLP cases were left-sided (55.3%). Seventy two percentage of cases occurred as NSF, and 20% had a recognized-syndrome ([Table 3](#t03){ref-type="table"}). The most frequently identified syndromes were Aarskog-Scott and Velocardiofacial ([Table 4](#t04){ref-type="table"}). Among the 288 (92.6%) of patients who had an additional congenital defect, musculoskeletal, cardiovascular, urogenital and nervous systems were the most common types. Among children 79.0% showed at least a morbidity ([Table 3](#t03){ref-type="table"}).

Table 2.Cleft type distribution according to sex.VariableFemaleMaleTotalCL13720CL±A448CLP91125216CP±A134CP412263TOTAL150161311[^3]

Table 3.Frequency of clinical forms, congenital anomalies with orofacial clefts and morbidities in Children and Adults^∗^Variablesn%Clinical formsMMF289.0NSF22472.0SF5919.0Total311Birth according to clinical form in childrenTerm birthMMF2111.0NSF13770.0SF3719.0Total195Preterm birthMMF34.0NSF4873.0SF1523.0Total66MorbiditiesChildren (\<18 yrs)04080.01510.02510.0≥30Total50Adults (18 ≥yrs)014154.016525.023814.6≥3176.4Total261Associated congenital anomalies with orofacial cleftsSystem or organNervous278.7Eye103.2Cardiovascular289.0Urogenital278.7Musculoskeletal16051.4Oral Cavity123.9Intergument247.7No237.4Total311[^4][^5]

Table 4.Frequency of syndromes associated to orofacial cleftsCodeMendelian Inheritance in Mann%305400Aarskog-Scott1017.0101200Apert11.7601701Arthrogryposis and Ectodermal Dysplasia11.7123500Crouzon11.7305100Ectodermal Dysplasia and Hypohidrotic 135.1129900Ectrodactily, Ectodermal Dysplasia and Cleft Lip Palate 111.7129830Ectrodactyly Cleft Palate11.7-Fetal Alcohol11.7164210Hemifacial Microsomia11.7601471Heriditary Congenital Facial Paresis 111.7142900Holt-Oram11.7300337Hypomelanosis of Ito11.7-Klinefelter11.7154700Marfan23.4163950Noonan11.76002510Oblique Facial Clefting 111.7311200Orofaciodigital 135.1133900Orofaciodigital 511.7304120Otopalatodigital 223.4261800Pierre Robin58.4119500Popliteal Pterygyum23.4106600Selective Tooth Agenesis 111.7117550Sotos23.4-Turner Syndrome11.7192350VACTERL association11.7119300Van der Woude 135.1192430Velocardiofacial1017.0Total59[^6]

The distribution of preterm birth was similar among MMF, SF and NSF populations. ([Table 5](#t05){ref-type="table"}). The only antenatal high-risk condition that showed significant statistical association with SF was the spectrum of Hypertensive Disorders in Pregnancy (*p*= 0.05). Preterm birth did not show significant statistical association with SF (*p*= 0.67). Heart diseases, respiratory failure, seizures, and developmental dysplasia of the hip had significant statistical associations with SF (*p*= 0.000, *p*= 0.0005, *p*= 0.002, *p*= 0.0006, respectively) ([Table 5](#t05){ref-type="table"}) .

**Table 5**.Association of SSF and NSF with antenatal high-risk conditions in Children and comorbidities among children and adults.VariablesSSFNSFnnTotalORpAntenatal riskPreterm LaborYes112No481842323.80.3700OligohydramniosYes167No481792270.61.0000HDPYes71118No421742162.60.0500Bleeding (unknown cause)Yes156No481802280.71.0000FGRYes167No481792270.61.0000Fetal distressYes112No481842323.80.3700PPRMYes123No481832311.90.5000ComorbiditiesRespiratory infectiousYes102636No391591981.60.3000Gastrointestinal Tract diseasesYes71330No421722142.20.1000Heart diseasesYes14216No3518321836.70.0000DDHYes639No431822258.50.0006Respiratory FailureYes7714No421782204.20.0005Diseases of the NewbornYes61622No431692121.50.4400OphthalmopathyYes347No461812272.950.1500CMOYes42731No451582030.50.2300SeizuresYes8513No4118022170.0020Kidney and urinary tract diseasesYes224No471832303.90.1500[^7]

Discussion
==========

The present work is the first complete epidemiological descriptive study about Orofacial Clefts in Colombia [@B11],[@B12],[@B14]. Our results are consistent with previously published studies of the distribution of OFC according to sex, affected-side and cleft type [@B06],[@B07],[@B15]-[@B17].

Aarskog-Scott syndrome (AAS) shows the highest frequency among SF. This observation differs from previously published papers, which reported Van der Woude Syndrome (VDW) as the most common [@B06],[@B07],[@B18]. Aarskog-Scott syndrome is an X-linked condition caused by mutations of the *FGD1* gene. It is a clinically and genetically heterogeneous condition characterized by facial dysmorphic features, short stature, brachydactyly, and genital anomalies [@B19],[@B20]. Although clinical manifestations and diagnostic criteria are well established, diagnosis is not simple, due to the extremely variable spectrum of phenotypical features [@B21],[@B22]. It is probable that AAS is being underdiagnosed and for that reason the frequency according to previous studies appears lower. Further studies must be.

However, geographical and ethnic factors of our population should be considered, given that they might influence the distribution of the SF with respect NSF. Research into *FGD1* founder mutations might be usefully conducted in future studies.

The musculoskeletal system is the most frequently affected among SF population according to this research. This result is consistent with reported findings by Calzolari *et al* [@B23]. This may reflect the impact of a number of genes which play an essential role in the development of connective tissue [@B04],[@B24].

According to Sekhon *et al*[@B25] facial anomalies are the most frequently detected, followed by ocular, central nervous system, lower and upper extremities and cardiovascular. Most of the facial, lower and upper extremities anomalies involve connective tissue. It is important to consider that the published prevalence of associated anomalies vary considerably depending on methodological factors [@B26].

The roles of antenatal high-risk conditions among the SF population have not been well studied. Our work provides the first evidence that there is an association between SF and hypertensive disorders in pregnancy in comparison with NSF (OR= 8.5) .

The etiology of SF is related to mutations within several genes involved in mesenchymal and epithelial proliferation, cell adhesion and migration and angiogenesis. All of these are essential for lip and palate development [@B07],[@B27],[@B28]. The disturbance of decidua-trophoblast interactions during early human pregnancy is one of the events implicated into the pathogenesis of hypertensive disorders in pregnancy [@B29]-[@B31]. These interactions depend largely on maternal uterine endothelial cells activated by expression of selectins that enable adherence of trophoblast to maternal endothelium [@B32],[@B33], and epithelial-mesenchymal transition during trophoblast differentiation [@B34],[@B35]. Given the above we propose that common processes may be disrupted in both entities: 1) cell adhesion mechanisms, 2) epithelial-mesenchymal transition, and 3) angiogenesis.

Transforming growth factor-beta 3 (*TGF-β3*), plays an essential role in these processes, and is known to be involved in the pathogenesis of hypertensive disorders in pregnancy [@B36]-[@B39] and some forms of OFCs [@B36],[@B40]. Therefore, it might be a candidate gene for both disorders. In order to test this hypothesis this gene should be investigated in patients and their mothers affected by SF and preeclampsia respectively. Associations of SF and developmental dysplasia of the hip (DDH) have not been reported in previous papers. The etiology of DDH is multifactorial, but has a considerable genetic component [@B41],[@B42]. Although oligohydramnios is a risk condition associated with DDH, the relationship between SF and oligohydramnios does not show significant statistical association according to this work. The causality relationships underlying this finding must be investigated with regard to the possibility of earlier hip screening among this population.

Desalu *et al*. [@B43], reported that anatomical abnormalities associated with cleft lip and palate increase the risk of airway complications and this is confirmed by comparing SF and NSF in the current study (OR= 4.2). Clinical features such as micrognathia [@B44] and congenital heart diseases are common in SF; these factors might be involved in this association.

Preterm birth and other antenatal high-risk conditions do not show significant statistical association with SF, probably due to limited power given the small set of observations.

The associations found in this study contribute to appropriate medical and risk management of the affected patients. Clinicians can be guided by this study in order to provide comprehensive care for the benefit of these patients and their families. Based on the findings of this work, we are performing molecular diagnosis of the SF cases. Establishing causality relationships between the studied variables is one of the central goals of our future studies.

Conclusion
==========

These data provide an epidemiological reference of Orofacial Clefts in Colombia. Novel associations between syndromic forms and clinical variables are determined. In order to investigate causality relationships between these variables further studies must be carried out.
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[^2]: m= month

[^3]: CL= cleft lip; CL±A= cleft lip with or without cleft alveolus; CLP= cleft lip and palate; CP±A= cleft palate with or without cleft alveolus; CP= cleft palate

[^4]: ^\*^Birth history was asked among pediatric population. Birth history is not included within Adult Medical History. Adults were not included in this analysis.

[^5]: MMF= Multiple malformation form; NSF= Non-syndromic form; SF= Syndromic form

[^6]: Code= From OMIM, Catalog of Human Genes and Genetic Disorders

[^7]: SSF= syndromic form; NSF= nonsyndromic form; HDP= Hypertensive Disorders in Pregnancy; FGR= Fetal growth restriction; PPRM= Preterm premature rupture of membrane; DDH= developmental dysplasia of the hip; OR= odds ratio
